Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-05-27 19:30 CEST (UTC+2h)
 

Follow-up: It gets worse! [Off Topic]

posted by ElMaestro - Denmark, 2017-04-18 10:01  - Posting: # 17245
Views: 439

Hi all,

surely I am going to burn in hell for this but given how completely hopeless that invitation was I sent this response to the organisers:

Dear Ms. [name],

I would like to humbly thank you for your invitation to WGC-2017.

Would you be interested if I give a talk in Theme 801 with the title: "Genomics in the new millenium: The apparent inability of Sequential Bioequivalence Designs to address important contemporary DNA-related topics such as recombination rate in transposon-rich regions of Chromosome VI of the European honey bee (Apis mellifera)" ?

I look forward to receiving your response.


This morning their answer was in my inbox:

I appreciate your feedback and welcome you give an oral presentation in this conference. The organizing committee is very interested in your lecture title.

Secondly, at this moment, may I ask if you could give your lecture abstract along with biography to me? Please be sure that both of abstract & biography should be limited in One Page. (Follow the format I attached).Since these materials will be included in our meeting proceeding in the future, please be aware that total amount of the characters should not exceed 2500.
Since speech solts are limited, please register on http://www.bitcongress.com/wgc2017/OnlineRegistration.asp to confirm your participation firstly and send the abstract to me a little later.


This little story is in a sense a good image of the sad state of affairs science sometimes finds itself in. Money talks. Facts and reason don't.

I could be wrong, but…


Best regards,
ElMaestro


GCP lecturer: "And who do we consider the most important person in a clinical trial?"
Principal Investigator: "Me!".

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
16,926 Posts in 3,627 Threads, 1,029 registered users;
12 users online (0 registered, 12 guests).

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed